About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Alopecia Treatment Market Size, Top Share, Demand, Forecast to 2033
Alopecia Treatment Market

Alopecia Treatment Market Size, Share & Trends Analysis Report By Drug Class (Minoxidil, Finasteride, Other Drug), By Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, Others), By Distribution Channels (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55169DR
Last Updated : January 27, 2025
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Alopecia Treatment Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Minoxidil
        1. By Value
      3. Finasteride
        1. By Value
      4. Other Drug
        1. By Value
    3. By Indication
      1. Introduction
        1. Indication By Value
      2. Androgenic Alopecia
        1. By Value
      3. Alopecia Areata
        1. By Value
      4. Alopecia Totalis
        1. By Value
      5. Others
        1. By Value
    4. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Minoxidil
        1. By Value
      3. Finasteride
        1. By Value
      4. Other Drug
        1. By Value
    3. By Indication
      1. Introduction
        1. Indication By Value
      2. Androgenic Alopecia
        1. By Value
      3. Alopecia Areata
        1. By Value
      4. Alopecia Totalis
        1. By Value
      5. Others
        1. By Value
    4. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    5. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Minoxidil
          1. By Value
        3. Finasteride
          1. By Value
        4. Other Drug
          1. By Value
      2. By Indication
        1. Introduction
          1. Indication By Value
        2. Androgenic Alopecia
          1. By Value
        3. Alopecia Areata
          1. By Value
        4. Alopecia Totalis
          1. By Value
        5. Others
          1. By Value
      3. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Minoxidil
        1. By Value
      3. Finasteride
        1. By Value
      4. Other Drug
        1. By Value
    3. By Indication
      1. Introduction
        1. Indication By Value
      2. Androgenic Alopecia
        1. By Value
      3. Alopecia Areata
        1. By Value
      4. Alopecia Totalis
        1. By Value
      5. Others
        1. By Value
    4. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    5. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Minoxidil
          1. By Value
        3. Finasteride
          1. By Value
        4. Other Drug
          1. By Value
      2. By Indication
        1. Introduction
          1. Indication By Value
        2. Androgenic Alopecia
          1. By Value
        3. Alopecia Areata
          1. By Value
        4. Alopecia Totalis
          1. By Value
        5. Others
          1. By Value
      3. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Minoxidil
        1. By Value
      3. Finasteride
        1. By Value
      4. Other Drug
        1. By Value
    3. By Indication
      1. Introduction
        1. Indication By Value
      2. Androgenic Alopecia
        1. By Value
      3. Alopecia Areata
        1. By Value
      4. Alopecia Totalis
        1. By Value
      5. Others
        1. By Value
    4. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    5. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Minoxidil
          1. By Value
        3. Finasteride
          1. By Value
        4. Other Drug
          1. By Value
      2. By Indication
        1. Introduction
          1. Indication By Value
        2. Androgenic Alopecia
          1. By Value
        3. Alopecia Areata
          1. By Value
        4. Alopecia Totalis
          1. By Value
        5. Others
          1. By Value
      3. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Minoxidil
        1. By Value
      3. Finasteride
        1. By Value
      4. Other Drug
        1. By Value
    3. By Indication
      1. Introduction
        1. Indication By Value
      2. Androgenic Alopecia
        1. By Value
      3. Alopecia Areata
        1. By Value
      4. Alopecia Totalis
        1. By Value
      5. Others
        1. By Value
    4. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    5. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Minoxidil
          1. By Value
        3. Finasteride
          1. By Value
        4. Other Drug
          1. By Value
      2. By Indication
        1. Introduction
          1. Indication By Value
        2. Androgenic Alopecia
          1. By Value
        3. Alopecia Areata
          1. By Value
        4. Alopecia Totalis
          1. By Value
        5. Others
          1. By Value
      3. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Minoxidil
        1. By Value
      3. Finasteride
        1. By Value
      4. Other Drug
        1. By Value
    3. By Indication
      1. Introduction
        1. Indication By Value
      2. Androgenic Alopecia
        1. By Value
      3. Alopecia Areata
        1. By Value
      4. Alopecia Totalis
        1. By Value
      5. Others
        1. By Value
    4. By Distribution Channels
      1. Introduction
        1. Distribution Channels By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    5. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Minoxidil
          1. By Value
        3. Finasteride
          1. By Value
        4. Other Drug
          1. By Value
      2. By Indication
        1. Introduction
          1. Indication By Value
        2. Androgenic Alopecia
          1. By Value
        3. Alopecia Areata
          1. By Value
        4. Alopecia Totalis
          1. By Value
        5. Others
          1. By Value
      3. By Distribution Channels
        1. Introduction
          1. Distribution Channels By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Alopecia Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Capillus LLC
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Cipla Inc.
    3. Daiichi Sankyo Company Limited
    4. GlaxoSmithKline Plc
    5. Johnson and Johnson
    6. Merck and Co., Inc.
    7. Sun Pharmaceutical Industries Ltd.
    8. Transitions Hair
    9. Vitabiotics Ltd.
    10. Vita-Cos-Med Klett-Loch GmbH
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Global Anthrax Treatment Market Size & Trends The global anthrax treatment market size was valued at USD 422.57 million in 2024 and is projected to grow from USD 453.15 million in 2025 to reach USD 697.82 million by 2033, exhibiting a CAGR of 5.
Buy Now
Global Report
global cancer treatment market size is expected to reach USD 171,266 million in 2026 from USD 98,069 million in 2018 at a CAGR of 7.3% during the forecast period 2019–2026 Cancer is caused by uncontrolled growth of abnormal cells in distinctiv
Buy Now
Global Report
Insomnia Treatment Market Size The global insomnia treatment market size was valued at USD 3,858.86 million in 2024 and is expected to grow from USD 4,098.11 million in 2025 to USD 6,631.00 million by 2033, growing at a CAGR of 6.20%
Buy Now
Global Report
The global seed treatment market size was valued at USD 8822.18 million in 2022. It is projected to reach USD 26041.42 million by 2031, growing at a CAGR of 12.78% during the forecast period (2023–2031). Seed treatment safeguards plants f
Buy Now
Global Report
Global Uveitis Treatment Market Size The global uveitis treatment market size was valued at USD 2.28 billion in 2024 and is expected to grow from USD 2.49 billion in 2025 to reach USD 4.88 billion by 2033, growing at a CAGR of 8.8% du
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.